Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Autoimmune hemolytic anemia


Other Names for this Disease

  • Acquired autoimmune hemolytic anemia
  • Anemia hemolytic autoimmune
  • Familial auto-immune hemolytic anemia (subtype)
  • Idiopathic autoimmune hemolytic anemia
  • Immuno-hemolytic anemia
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Overview

Autoimmune hemolytic anemia (AIHA) occurs when your immune system makes antibodies that attack your red blood cells. This causes a drop in the number of red blood cells, leading to hemolytic anemia. Symptoms may include unusual weakness and fatigue with tachycardia and breathing difficulties, jaundice, dark urine and/or splenomegaly. AIHA can be primary (idiopathic) or result from an underlying disease or medication. The condition may develop gradually or occur suddenly.[1][2] There are two main types of autoimmune hemolytic anemia: warm antibody hemolytic anemia and cold antibody hemolytic anemia.[2][3][4] Treatment may include corticosteroids such as prednisone, splenectomy, immunosuppressive drugs and/or blood transfusions.[3]
Last updated: 12/19/2012

References

  1. Idiopathic autoimmune hemolytic anemia. MedlinePlus. January 2010; http://www.nlm.nih.gov/medlineplus/ency/article/000579.htm. Accessed 12/19/2012.
  2. Michel M. Autoimmune hemolytic anemia. Orphanet. August 2010; http://www.orpha.net/consor/cgi-bin/Disease_Search.php?lng=EN&data_id=13392. Accessed 12/19/2012.
  3. Lichtin AE. Autoimmune Hemolytic Anemia. Merck Manual. June 2008; http://www.merckmanuals.com/home/blood_disorders/anemia/autoimmune_hemolytic_anemia.html. Accessed 12/19/2012.
  4. Types of Hemolytic Anemia. National Heart Lung and Blood Institute (NHLBI). April 2011; http://www.nhlbi.nih.gov/health/health-topics/topics/ha/types.html. Accessed 12/19/2012.
Your Questions Answered
by the Genetic and Rare Diseases Information Center

1 question(s) from the public on Autoimmune hemolytic anemia have been answered. See questions and answers. You can also submit a new question.

Basic Information

  • MedlinePlus was designed by the National Library of Medicine to help you research your health questions, and it provides more information about this topic.
  • The Merck Manuals Online Medical Library provides information on this condition for patients and caregivers. 
  • The National Heart, Lung, and Blood Institute (NHLBI) provides leadership for a national program in diseases of the heart, blood vessels, lung, and blood; blood resources; and sleep disorders. Since October 1997, the NHLBI has also had administrative responsibility for the NIH Woman's Health Initiative. Click on the link to view information on this topic.
  • The National Organization for Rare Disorders (NORD) is a federation of more than 130 nonprofit voluntary health organizations serving people with rare disorders. Click on the link to view information on this topic.

In Depth Information

  • The Online Mendelian Inheritance in Man (OMIM) is an catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine. 
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs.  Access to this database is free of charge.
  • PubMed is a searchable database of medical literature and lists journal articles that discuss Autoimmune hemolytic anemia. Click on the link to view a sample search on this topic.
Other Names for this Disease
  • Acquired autoimmune hemolytic anemia
  • Anemia hemolytic autoimmune
  • Familial auto-immune hemolytic anemia (subtype)
  • Idiopathic autoimmune hemolytic anemia
  • Immuno-hemolytic anemia
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.